About Janux Therapeutics, Inc. 
Janux Therapeutics, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 57 Schemes (34.23%)
Foreign Institutions
Held by 124 Foreign Institutions (13.52%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
(Quarterly Results - Dec 2025)
Net Profit:
-32 Million
Pharmaceuticals & Biotechnology
USD 850 Million (Small Cap)
NA (Loss Making)
NA
0.00%
-1.01
-10.43%
0.87






